CH ENV TECH & BIO(01237)
Search documents
中科生物(01237) - 月报表
2025-10-02 14:30
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致:香港交易及結算所有限公司 公司名稱: 中科生物控股有限公司 呈交日期: 2025年10月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01237 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 200,000,000 | HKD | | 0.5 | HKD | | 100,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 200,000,000 | HKD | | 0.5 | HKD | | 100,000,000 | 本月底法定/註冊股本總額: ...
中科生物(01237) - 致非登记持有人的通知信函及回条
2025-09-26 14:28
CHINA ENVIRONMENTAL TECHNOLOGY AND BIOENERGY HOLDINGS LIMITED 中科生物控股有限公司 (Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) (Stock Code 股份代號: 1237) N O T I F I C AT I O N L E T T E R 通 知 信 函 26 September 2025 Dear non-registered shareholder(s), China Environmental Technology and Bioenergy Holdings Limited (the "Company") - Notice of Publication of 2025 Interim Report (the "Current Corporate Communications") The Current Corporate Communications of the Company has been published in E ...
中科生物(01237) - 致登记持有人的通知信函及回条
2025-09-26 14:27
CHINA ENVIRONMENTAL TECHNOLOGY AND BIOENERGY HOLDINGS LIMITED 中科生物控股有限公司 (Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) (Stock Code 股份代號: 1237) By order of the Board China Environmental Technology and Bioenergy Holdings Limited Xie Qingmei Chairlady N O T I F I C AT I O N L E T T E R 通 知 信 函 Dear registered shareholder(s), 26 September 2025 China Environmental Technology and Bioenergy Holdings Limited (the "Company") - Notice of Publication of 2025 Interim Report (the "Current ...
中科生物(01237) - 2025 - 中期财报
2025-09-26 14:26
Revenue and Profitability - The Group's revenue increased by 7.0% to RMB199.5 million during the first half of 2025, compared to RMB186.5 million in the same period of 2024[12]. - Revenue for the six months ended June 30, 2025, increased by 6.8% to RMB199.5 million compared to RMB186.5 million in the same period of 2024[22]. - Revenue from wooden products, the largest income stream, accounted for 99.3% of total sales, with an increase to RMB198.1 million from RMB185.4 million[22]. - Revenue from renewable energy products rose by 34.1% to approximately RMB1.4 million, up from RMB1.1 million in 2024[23]. - The Group recorded a profit of approximately RMB8.8 million for the period, a turnaround from a loss of RMB1.7 million in 2024[34]. - Profit for the period attributable to owners of the Company was RMB8,752,000, a significant recovery from a loss of RMB1,715,000 in the prior year[117]. - Total comprehensive income for the period was RMB12,525,000, up from RMB4,302,000 in the previous year, reflecting a year-over-year increase of approximately 191%[119]. - The reportable segment profit for the six months ended June 30, 2025, was RMB7,290,000, compared to a loss of RMB347,000 in the same period of 2024, indicating a significant turnaround[160]. Cost and Expenses - Selling and distribution expenses decreased by 39.1% to RMB6.6 million, compared to RMB10.8 million in 2024[26]. - Administrative expenses increased to RMB18.4 million from RMB18.0 million, mainly due to higher research and development costs[31]. - Finance costs decreased to approximately RMB3.6 million from RMB8.8 million, reflecting lower interest payments on bank loans[32]. - Research and development costs for the six months ended June 30, 2025, were RMB4,435,000, down from RMB5,410,000 in 2024, a decrease of 18%[168]. Assets and Liabilities - As of June 30, 2025, current assets were RMB535.4 million, with cash and cash equivalents at RMB33.8 million[35]. - Total liabilities increased to RMB378,288,000 from RMB335,972,000, reflecting a rise of approximately 12.5%[122]. - The company's equity increased to RMB887,381,000 as of June 30, 2025, compared to RMB874,856,000 at the end of 2024, showing a growth of about 1.5%[122]. - The company reported an increase in trade and other receivables to RMB190,680,000 from RMB157,009,000, which is an increase of approximately 21.5%[121]. - The Group's inventories totaled RMB114,538,000 as of June 30, 2025, down from RMB123,652,000 as of December 31, 2024[178]. Market and Economic Environment - The overall economic environment remains unstable, affecting customer purchasing behavior and market dynamics[18]. - The outlook for Chinese wooden product exports in 2025 is cautiously optimistic, driven by a rebound in global housing demand and cross-border e-commerce growth[53]. - Manufacturers face significant challenges including stringent EU sustainability regulations, persistent U.S. tariffs, and intense competition from Southeast Asian producers[55]. Strategic Focus and Future Outlook - The Group's core business segments remain focused on manufacturing wooden products and renewable energy, with a strategic emphasis on sustainability[17]. - The Group continues to explore opportunities for market expansion and product development in response to changing market conditions[19]. - Future outlook includes a commitment to improving operational efficiency and enhancing product offerings to meet customer demands[19]. Shareholder Information and Corporate Governance - As of June 30, 2025, Mr. Wu Zheyan holds a total of 20,452,488 shares, representing approximately 22.20% of the total shareholding[64]. - The Company proposed to adopt the 2025 Share Award Scheme, which will also be valid for ten years from the adoption date[100]. - The Company did not declare any interim dividend for the period[103]. - The audit committee has reviewed the unaudited interim financial report for the period, ensuring compliance with accounting principles and policies[112]. - The Company has complied with the Corporate Governance Code, except for specific provisions regarding board meeting frequency and management updates[105][106]. Cash Flow and Financing Activities - The cash flow from operating activities showed a net cash outflow of RMB6,188,000 for the six months ended June 30, 2025, compared to a net cash inflow of RMB20,811,000 in the same period of 2024[127]. - The company incurred a net cash outflow of RMB28,089,000 from investing activities during the first half of 2025, compared to a net cash outflow of RMB76,011,000 in the same period of 2024[128]. - The net cash from financing activities was RMB40,766,000 for the six months ended June 30, 2025, an increase from RMB36,296,000 in the same period of 2024[128]. Segment Information - The Group has identified two reportable segments: Manufacturing and sales of wooden products, and Manufacturing and sales of renewable energy products, with no aggregation of operating segments[149]. - Revenue from external customers in the manufacturing and sales of wooden products segment increased to RMB198,090,000 in 2025 from RMB185,431,000 in 2024, reflecting a growth of 6.5%[159]. - The Group's revenue recognition is based on products transferred at a point in time, with all revenue recognized in this manner for both segments[145].
中科生物(01237) - 致非登记持有人的通知信函及回条
2025-09-22 14:41
CHINA ENVIRONMENTAL TECHNOLOGY AND BIOENERGY HOLDINGS LIMITED 中科生物控股有限公司 (Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) (Stock Code 股份代號: 1237) N O T I F I C AT I O N L E T T E R 通 知 信 函 22 September 2025 By order of the Board China Environmental Technology and Bioenergy Holdings Limited Xie Qingmei Chairlady 各位非登記股東: 中科生物控股有限公司(「公司」) – 股東特別大會通函及股東特別大會通告(「本次公司通訊」)的刊發通知 本次公司通訊文件備有中、英文版本,並已上載於香港聯合交易所有限公司(「香港交易所」)網站(www.hkexnews.hk)及公司網站 (www.merrygardenholdings.com),歡迎瀏覽。 閣下若因任何理 ...
中科生物(01237) - 致登记持有人的通知信函及回条
2025-09-22 14:40
CHINA ENVIRONMENTAL TECHNOLOGY AND BIOENERGY HOLDINGS LIMITED 中科生物控股有限公司 (Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) (Stock Code 股份代號: 1237) N O T I F I C AT I O N L E T T E R 通 知 信 函 22 September 2025 Dear registered shareholder(s), If the Company does not receive a functional email address in your reply, until such time that the functional email address is provided to the Share Registrar, you will (i) be unable to receive any notifications regarding the publication of Corp ...
中科生物(01237) - 股份奖励计划规则
2025-09-22 14:39
中科生物控股有限公司 於 二零二五年[日期] 採納的 股份獎勵計劃規則 1. 宗旨 計劃旨在(i)為本公司提供靈活的方式,以便向合資格參與者提供報酬、激勵、 挽留、獎勵、補償合資格參與者及╱或向合資格參與者提供福利;(ii) 通過向 合資格參與者提供獲得本公司所有權權益及成為股東的機會,使彼等的利益 與本公司及股東的利益一致,從而激勵彼等盡力為本集團利益而提升表現及 效率,特別是在實現本集團戰略目標方面;(iii)鼓勵合資格參與者為本公司的 長期增長、表現及盈利能力作出貢獻,並為本公司及股東的整體利益提高本 公司及其股份的價值;及(iv) 吸引及挽留對本集團作出積極貢獻或將會或預 期對本集團有積極貢獻的合資格參與者,或以其他方式與彼等維持持續業務 關係。 2. 管理層 計劃須由管理層根據規則執行。管理層的決定對所有受其影響的人士具有最 終性及約束力,並受限於董事會的總體權限。 3. 合資格參與者 管理層可不時選擇任何合資格參與者作為經選定參與者,於計劃期間向該經 選定參與者授予獎勵,並釐定獎勵的條款及條件及獎勵股份的歸屬。合資格 參與者包括僱員參與者、關聯實體參與者及服務提供商,前提為其並非除外 參與者。 1 ...
中科生物(01237) - 於二零二五年十月十六日举行的股东特别大会适用的代表委任表格
2025-09-22 14:28
CHINA ENVIRONMENTAL TECHNOLOGY AND BIOENERGY HOLDINGS LIMITED 中科生物控股有限公司 於二零二五年十月十六日舉行的股東特別大會適用的代表委任表格 本表格所用詞彙與中科生物控股有限公司(「本公司」)日期為二零二五年九月二十二日的通函內所界定者具有相同涵義。 本人╱吾等 (附註1) 地址為 (附註2) 的登記持有人, 茲委任大會主席或 (附註3及4) 地址為 (於開曼群島註冊成立的有限公司) (股份代號:1237) 為本公司股本中每股面值0.05港元的普通股 股 | | 普通決議案 (附註7) | 贊成 (附註5) | 反對 (附註5) | | --- | --- | --- | --- | | 1. | 批准二零二五年股份獎勵計劃 | | | | 2. | 批准服務提供商分項限額 | | | 日期:二零二五年 月 日 股東簽署 (附註6) 附註: 1. 請用正楷填寫全名及地址。所有聯名持有人的名稱均應填寫。 2. 請填上以 閣下名義登記的本公司股份數目;倘未填寫股份數目,則本代表委任表格將被視為與所有以 閣下名義登記的本公司股本中的 股份有關。 3. ...
中科生物(01237) - 股东特别大会通告
2025-09-22 14:28
香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責, 對其準確性或完整性亦不發表任何聲明,並明確表示概不就因本公佈全部或任何 部份內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 CHINA ENVIRONMENTAL TECHNOLOGY AND BIOENERGY HOLDINGS LIMITED (於開曼群島註冊成立的有限公司) 中科生物控股有限公司 普通決議案 1. 審議及酌情通過(不論有否修訂)以下決議案為普通決議案: 「動議: 1 (a) 待聯交所上市委員會批准根據本公司股份獎勵計劃(「二零二五年股份 獎勵計劃」)(有關規則(「二零二五年股份獎勵計劃規則」)載於註有「A」 字樣並已呈交股東特別大會由股東特別大會主席簡簽以資識別的文件) 可予授出的獎勵(「股份獎勵」)獲歸屬而可能須予配發及發行的本公司 股份(「股份」)上市及買賣後,謹此批准二零二五年股份獎勵計劃,及採 納二零二五年股份獎勵計劃規則作為二零二五年股份獎勵計劃之規則, 以及授權董事、薪酬委員會及上述代表在其可能認為屬必要或權宜的情 況下為全面落實二零二五年股份獎勵計劃而採取一切有關行動及作出一 切有關交易、安 ...
中科生物(01237) - 建议採纳二零二五年股份奖励计划及股东特别大会通告
2025-09-22 14:27
香港交易及結算所有限公司及香港聯合交易所有限公司對本通函的內容概不負責,對其準確 性或完整性亦不發表任何聲明,並明確表示不會就本通函全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 CHINA ENVIRONMENTAL TECHNOLOGY AND BIOENERGY HOLDINGS LIMITED 中科生物控股有限公司 (於開曼群島註冊成立的有限公司) (股份代號:1237) 此乃要件 請即處理 閣下如對本通函的任何方面或擬採取的行動有任何疑問,應諮詢股票經紀或其他註冊證券交 易商、銀行經理、律師、專業會計師或其他專業顧問。 閣下如已出售或轉讓名下所有中科生物控股有限公司(「本公司」)股份,應立即將本通函連同 代表委任表格送交買主或承讓人或經手買賣或轉讓的銀行、股票經紀或其他代理人,以便轉交 買主或承讓人。 建議採納二零二五年股份獎勵計劃 及 股東特別大會通告 謹訂於二零二五年十月十六日(星期四)下午二時正假座中國福建省漳平市富山工業園區舉行 股東特別大會,召開股東特別大會的通告載於本通函第35至38頁。 本通函連同股東特別大會適用的代表委任表格登載於香港交易及結算所有限公司網站 ...